$133.15+12.95% · 3M
Moving avg
1W-2.63%
1M+6.61%
3M+12.95%
6M-4.90%
YTD+8.66%
1Y-4.54%
3Y+8.26%
5Y+0.35%
52-week range
$103.2349% of range$164.28
Company health
Value3/6
Growth2/6
Profitability4/6
Health4/6
Dividend5/6
Bull vs bear
Strengths
- Analysts see 19% upside to a $158 target
- Analyst consensus is "Buy"
- High return on equity (1433%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$8.50B
Enterprise value
$9.42B
P/E ratio (TTM)
21.83x
P/S ratio (TTM)
2.13x
EV/EBITDA
11.28x
Per share & returns
EPS (TTM)
$6.04
Dividend yield
1.47%
Beta (1Y)
0.39
30-day change
+6.61%
Trading
Volume (24h)
231.64K
Previous close
$134.75
Shares outstanding
63.82M
About AptarGroup, Inc.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Symbol
ATR
AptarGroup, Inc. is a mid-cap healthcare company in the Medical - Instruments & Supplies industry. Its shares are listed on NYSE (United States) and trade under the ticker ATR.
Frequently asked questions
What is AptarGroup, Inc.'s market cap?
AptarGroup, Inc. (ATR) has a market capitalization of $8.50B.
What is AptarGroup, Inc.'s P/E ratio?
AptarGroup, Inc. trades at a price-to-earnings (P/E) ratio of 21.83.
What exchange does ATR trade on?
ATR trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.40-0.30%
$356.38B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.72-0.39%
$288.92B cap
AstraZeneca PLCLON: AZN
£116.38-0.55%
$243.29B cap